Objective: The purpose of this study was to assess the long-term outco
me of patients with tardive dyskinesia. Method: A group of 122 neurole
ptic-treated Hungarian outpatients were assessed for tardive dyskinesi
a on the Abnormal Involuntary Movement Scale and the Tardive Dyskinesi
a Rating Scale by the same rater over a 10-year period. Results: Sixty
-three of the patients received both 5- and 10-year follow-up assessme
nts and are the subjects of this report. The overall prevalence of tar
dive dyskinesia in this group changed little over time; it was 30.2% a
t baseline, 36.5% at 5 years, and 31.7% at 10 years. However, there we
re changes in the tardive dyskinesia status of individual patients; 11
patients had remissions, and 12 who did not have tardive dyskinesia a
t the baseline assessment had developed it by the 10-year assessment.
These two subgroups did not differ significantly on demographic and dr
ug history variables. Outcome of tardive dyskinesia was not significan
tly related to neuroleptic treatment or to age. Conclusions: The data
of this 10-year follow-up study provide evidence for the long-term sta
bility of tardive dyskinesia and for the feasibility of maintenance ne
uroleptic therapy for chronic psychotic patients who have tardive dysk
inesia.